Alexander Pintzas

2.8k total citations · 1 hit paper
50 papers, 2.4k citations indexed

About

Alexander Pintzas is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Alexander Pintzas has authored 50 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 24 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Alexander Pintzas's work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (12 papers) and Genetic factors in colorectal cancer (8 papers). Alexander Pintzas is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (12 papers) and Genetic factors in colorectal cancer (8 papers). Alexander Pintzas collaborates with scholars based in Greece, France and United Kingdom. Alexander Pintzas's co-authors include Angeliki Voulgari, Eftychia Oikonomou, Ladislav Anděra, Takehiko Sasazuki, Senji Shirasawa, Κωνσταντίνος Δροσόπουλος, Bohdan Wasylyk, Sauveur-Michel Maira, Peter Sobieszczuk and Angelo Ferraro and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and PLoS ONE.

In The Last Decade

Alexander Pintzas

50 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epithelial–mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic

2009 581 citations Angeliki Voulgari, Alexander Pintzas profile →

Peers

Countries citing papers authored by Alexander Pintzas

Since Specialization

Citations

This map shows the geographic impact of Alexander Pintzas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Pintzas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Pintzas more than expected).

Fields of papers citing papers by Alexander Pintzas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Pintzas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Pintzas. The network helps show where Alexander Pintzas may publish in the future.

Co-authorship network of co-authors of Alexander Pintzas

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Pintzas. A scholar is included among the top collaborators of Alexander Pintzas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Pintzas. Alexander Pintzas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer 2025 ·Molecular Oncology ·(unknown), Konstantinos Voutetakis, Vivian Kosmidou, (unknown), (unknown), (unknown), (unknown), Kymberleigh A. Pagel, Stephan Wolf, Gregor Warsow, Antonia Dimitrakopoulou‐Strauss, Georgios Zografos, Alexander Pintzas, Johannes Betge, Olga Papadodima, Stefan Wiemann	1
2	Antitumorigenic Effect of Combination Treatment with BRAF Inhibitor and Cisplatin in Colorectal Cancer In Vitro and In Vivo 2024 ·Advanced Therapeutics ·(unknown), (unknown), Vivian Kosmidou, (unknown), Maria Goulielmaki, Vassilis Zoumpourlis, Alexander Pintzas, Vassilis L. Souliotis	1
3	BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600Ε CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown), (unknown), Vivian Kosmidou, (unknown), Eftichia Kritsi, Maria I. Zervou, Aristotelis Chatziioannou, Vassilis L. Souliotis, Olga Papadodima, Alexander Pintzas	23
4	EZH2 Regulates Cofilin Activity and Colon Cancer Cell Migration by Targeting ITGA2 Gene 2014 ·PLoS ONE ·Angelo Ferraro, (unknown), Alexander Pintzas	49
5	Epigenetic regulation of miR-21 in colorectal cancer 2013 ·Epigenetics ·Angelo Ferraro, Christos K. Kontos, (unknown), Ioannis Bantounas, (unknown), Vivian Kosmidou, (unknown), (unknown), (unknown), George Zografos, Alexander Pintzas	99
6	EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control Epithelial–Mesenchymal Transition and anoikis in colon cancer cells 2012 ·The International Journal of Biochemistry & Cell Biology ·Angelo Ferraro, (unknown), Vivian Kosmidou, (unknown), George Kontogeorgos, George Zografos, Alexander Pintzas	58
7	Sensitization of (colon) cancer cells to death receptor related therapies 2012 ·Cancer Biology & Therapy ·Alexander Pintzas, Boris Zhivotovsky, Paul Workman, Paul A. Clarke, Spiros Linardopoulos, Jean‐Claude Martinou, Juan Carlos Lacal, Sylvie Robine, George Nasioulas, Ladislav Anděra	4
8	BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study 2011 ·Molecular Cancer ·(unknown), Eftychia Oikonomou, Michal Koc, Ladislav Anděra, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas	121
9	Selective BRAFV600E Inhibitor PLX4720, Requires TRAIL Assistance to Overcome Oncogenic PIK3CA Resistance 2011 ·PLoS ONE ·Eftychia Oikonomou, Michal Koc, (unknown), Ladislav Anděra, Alexander Pintzas	34
10	The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage 2010 ·Molecular and Cellular Neuroscience ·Niall C. H. Kerr, Alexander Pintzas, Fiona E. Holmes, (unknown), Robert J. P. Pope, Mark S. Wallace, Christine Wasylyk, Bohdan Wasylyk, David Wynick	18
11	TRAIL receptor upregulation and the implication of KRAS/BRAF mutations in human colon cancer tumors 2009 ·International Journal of Cancer ·Eftychia Oikonomou, Vivian Kosmidou, (unknown), (unknown), (unknown), George Kontogeorgos, Ladislav Anděra, Georgios Zografos, Alexander Pintzas	17
12	BRAFV600E Efficient Transformation and Induction of Microsatellite Instability Versus KRASG12V Induction of Senescence Markers in Human Colon Cancer Cells 2009 ·Neoplasia ·Eftychia Oikonomou, (unknown), (unknown), (unknown), Lesley Probert, Alexander Pintzas	36
13	Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects 2007 ·Expert Opinion on Therapeutic Targets ·Κωνσταντίνος Δροσόπουλος, Alexander Pintzas	6
14	Fra‐1 regulates vimentin during Ha‐RAS‐induced epithelial mesenchymal transition in human colon carcinoma cells 2007 ·International Journal of Cancer ·(unknown), (unknown), Angeliki Voulgari, Alexander Pintzas	61
15	Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha- RAS -transformed human colon cells 2006 ·Carcinogenesis ·(unknown), (unknown), Michael L. Roberts, Takehiko Sasazuki, Senji Shirasawa, Alexander Pintzas	105
16	Microarray analysis of the differential transformation mediated by Kirsten and Harvey Ras oncogenes in a human colorectal adenocarcinoma cell line 2005 ·International Journal of Cancer ·Michael L. Roberts, Κωνσταντίνος Δροσόπουλος, (unknown), (unknown), Era Taoufik, Christian Maercker, Apostolia Guialis, Μichael N. Alexis, Alexander Pintzas	36
17	Ecdysone-inducible expression of oncogenic Ha-Ras in NIH 3T3 cells leads to transient nuclear localization of activated extracellular signal-regulated kinase regulated by mitogen-activated protein kinase phosphatase-1 2002 ·Biochemical Journal ·David Plows, Paraskevi Briassouli, Carolyn A. Owen, (unknown), Michelle D. Garrett, Alexander Pintzas	12
18	Role of matrix metalloproteinase‐9 in progression of mouse skin carcinogenesis 2001 ·Molecular Carcinogenesis ·Alexandra Papathoma, Vassilis Zoumpourlis, Allan Balmain, Alexander Pintzas	29
19	Net, a new ets transcription factor that is activated by Ras. 1994 ·Genes & Development ·(unknown), Alexander Pintzas, Sauveur-Michel Maira, Peter Sobieszczuk, Bohdan Wasylyk	201
20	Human immunodeficiency virus long terminal repeat responds to transformation by the mutant T24 H-ras1 oncogene and it contains multiple AP-1 binding TPA-inducible consensus sequence elements. 1989 ·PubMed ·Demetrios�� Spandidos, M Yiagnisis, Alexander Pintzas	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact